Home Evaluation of high resolution gel β2-transferrin for detection of cerebrospinal fluid leak
Article
Licensed
Unlicensed Requires Authentication

Evaluation of high resolution gel β2-transferrin for detection of cerebrospinal fluid leak

  • Christopher R. McCudden EMAIL logo , Brent A. Senior , Shirley Hainsworth , Walter Oliveira , Lawrence M. Silverman , David E. Bruns and Catherine A. Hammett-Stabler
Published/Copyright: September 28, 2012

Abstract

Background: Cerebrospinal fluid (CSF) leaks are potentially life-threatening conditions that can be diagnosed by detection of β2-transferrin using protein electrophoresis. Another less commonly available test is β-trace protein quantitation using immunoassay. The objectives of this study were to evaluate a new immunofixation-based β2-transferrin test for detection of CSF leaks and to compare it to an existing agarose gel electrophoresis test and β-trace protein immunoassay.

Methods: For method comparison, 63 consecutive samples from physician-ordered β2-transferrin tests were analyzed using two different electrophoresis methods, agarose gel fractionation followed by acid-violet staining, and high resolution agarose gel electrophoresis followed by β2-transferrin immunofixation. A subset of samples (16/63) were analyzed for β-trace protein. Results were compared against patient chart data for the presence of a CSF leak. Additional studies were performed to assess the stability, detection limit, and analytical specificity of the β2-transferrin immunofixation test.

Results: The β2-transferrin immunofixation test had a sensitivity of 100% (40/40) and specificity of 71% (12/17) for detection of CSF leaks. By comparison, the agarose gel test had a sensitivity of 87% (35/40) and specificity of 94% (16/17). β-trace protein had a sensitivity of 100% (10/10) and specificity of 86% (5/6). Serum and saliva could be differentiated from CSF by the β2-transferrin immunofixation test based on their migration patterns. However, whole blood samples appeared positive for β2-transferrin at a threshold of ∼4 g/L hemoglobin. At a cut-off of 3 mg/L, β-trace protein was increased in 10/10 cases with documented CSF leak and in 1/6 patients without CSF leak.

Conclusions: Both the new immunofixation test for β2-transferrin and the β-trace protein were effective at detecting CSF leaks. Users of the β2-transferrin immunofixation test should be cautioned against interpreting samples with blood contamination.


Corresponding author: Christopher R. McCudden, PhD, NRCC, FACB, DABCC, Division of Biochemistry, Department of Pathology and Laboratory Medicine, University of Ottawa, The Ottawa Hospital, 501 Smyth Road, Ottawa ON, Canada, K1H 8L6, Phone: +1 613 7378899 ext. 74850

We gratefully acknowledge Sebia, USA for providing β2-transferrin immunofixation kits.

Conflict of interest statement

Author’s conflict of interest disclosure: The author stated that there are no conflicts of interest regarding the publication of this article.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

References

1. Görögh T, Rudolph P, Meyer JE, Werner JA, Lippert BM, Maune S. Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids. Clin Chem 2005;51:1704–10.10.1373/clinchem.2005.054916Search in Google Scholar

2. Papadea C, Schlosser RJ. Rapid method for beta2-transferrin in cerebrospinal fluid leakage using an automated immunofixation electrophoresis system. Clin Chem 2005;51:464–70.10.1373/clinchem.2004.042697Search in Google Scholar

3. Schnabel C, Di Martino E, Gilsbach JM, Riediger D, Gressner AM, Kunz D. Comparison of beta2-transferrin and beta-trace protein for detection of cerebrospinal fluid in nasal and ear fluids. Clin Chem 2004;50:661–3.10.1373/clinchem.2003.024158Search in Google Scholar PubMed

4. Bachmann G, Nekic M, Michel O. Clinical experience with beta-trace protein as a marker for cerebrospinal fluid. Ann Otol Rhinol Laryngol 2000;109:1099–102.10.1177/000348940010901202Search in Google Scholar PubMed

5. Burkhard PR, Rodrigo N, May D, Sztajzel R, Sanchez JC, Hochstrasser DF, et al. Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approach. Electrophoresis 2001;22:1826–33.10.1002/1522-2683(200105)22:9<1826::AID-ELPS1826>3.0.CO;2-LSearch in Google Scholar PubMed

6. Marshall AH, Jones NS, Robertson IJ. An algorithm for the management of CSF rhinorrhoea illustrated by 36 cases. Rhinology 1999;37:182–5.Search in Google Scholar PubMed

7. Meco C, Oberascher G. Comprehensive algorithm for skull base dural lesion and cerebrospinal fluid fistula diagnosis. Laryngoscope 2004;114:991–9.10.1097/00005537-200406000-00007Search in Google Scholar PubMed

8. Payne RJ, Frenkiel S, Glikstein R, Mohr G. Role of computed tomographic cisternography in the management of cerebrospinal fluid rhinorrhea. J Otolaryngol 2003;32:93–100.10.2310/7070.2003.37260Search in Google Scholar PubMed

9. Zapalac JS, Marple BF, Schwade ND. Skull base cerebrospinal fluid fistulas: a comprehensive diagnostic algorithm. Otolaryngol Head Neck Surg 2002;126:669–76.10.1067/mhn.2002.125755Search in Google Scholar PubMed

10. Sanders EL, Clark RJ, Katzmann JA. Cerebrospinal fluid leakage: agarose gel electrophoresis detection of beta(2)-transferrin and nephelometric quantification of beta-trace protein. Clin Chem 2004;50:2401–3.10.1373/clinchem.2004.040246Search in Google Scholar PubMed

11. Grantham VV, Blakley B, Winn J. Technical review and considerations for a cerebrospinal fluid leakage study. J Nucl Med Technol 2006;34:48–51.Search in Google Scholar PubMed

12. Normansell DE, Stacy EK, Booker CF, Butler TZ. Detection of beta-2 transferrin in otorrhea and rhinorrhea in a routine clinical laboratory setting. Clin Diagn Lab Immunol 1994;1: 68–70.10.1128/cdli.1.1.68-70.1994Search in Google Scholar

13. Bachmann G, Petereit H. Beta-trace protein as sensitive marker for liquorrhea. Acta Neurol Scand 2004;110:337–8; author reply 339.10.1111/j.1600-0404.2004.00318.xSearch in Google Scholar PubMed

14. Canty A, Ripley BD. Boot: Bootstrap R (S-Plus) Functions; 2-01. R package version 1.3-4.Search in Google Scholar

15. Davison AC, Hinkley DV. Bootstrap methods and their applications. Cambridge: Cambridge University Press, 1997.10.1017/CBO9780511802843Search in Google Scholar

16. Team RDC. R: A language and environment for statistical computing 2011.Search in Google Scholar

17. Snyder JA, Rogers MW, King MS, Phillips JC, Chapman JF, Hammett-Stabler CA. The impact of hemolysis on Ortho-Clinical Diagnostic’s ECi and Roche’s elecsys immunoassay systems. Clin Chim Acta 2004;348:181–7.10.1016/j.cccn.2004.05.017Search in Google Scholar PubMed

18. Reiber H. Beta-trace protein concentration in nasal secretion: discrepancies and flaws in recent publications. Acta Neurol Scand 2004;110:339–41.10.1111/j.1600-0404.2004.00317.xSearch in Google Scholar

19. Reiber H, Walther K, Althaus H. Beta-trace protein as sensitive marker for CSF rhinorhea and CSF otorhea. Acta Neurol Scand 2003;108:359–62.10.1034/j.1600-0404.2003.00173.xSearch in Google Scholar PubMed

20. Bachmann G, Petereit H, Djenabi U, Michel O. Predictive values of beta-trace protein (prostaglandin D synthase) by use of laser-nephelometry assay for the identification of cerebrospinal fluid. Neurosurgery 2002;50:571–6; discussion 576–7.10.1227/00006123-200203000-00027Search in Google Scholar

21. Buchman CA, Luxford WM, Hirsch BE, Fucci MJ, Kelly RH. Beta-2 transferrin assay in the identification of perilymph. Am J Otol 1999;20:174–8.Search in Google Scholar

Received: 2012-06-25
Accepted: 2012-08-18
Published Online: 2012-09-28
Published in Print: 2013-02-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Letters to the Editor
  2. Performance evaluation of three different immunoassays for detection of antibodies to hepatitis B core
  3. Serum homocysteine concentrations in Chinese children with autism
  4. Interchangeability of venous and capillary HbA1c results is affected by oxidative stress
  5. Interference of hemoglobin (Hb) N-Baltimore on measurement of HbA1c using the HA-8160 HPLC method
  6. First human isolate of Mycobacterium madagascariense in the sputum of a patient with tracheobronchitis
  7. Protein S and protein C measurements should not be undertaken during vitamin K antagonist therapy
  8. α2-HS glycoprotein is an essential component of cryoglobulin associated with chronic hepatitis C
  9. An unusual interference in CK MB assay caused by a macro enzyme creatine phosphokinase (CK) type 2 in HIV-infected patients
  10. An automated technique for the measurement of the plasma glutathione reductase activity and determination of reference limits for a healthy population
  11. Is osteopontin stable in plasma and serum?
  12. Evidence-based approach to reducing perceived wasteful practices in laboratory medicine
  13. Masthead
  14. Masthead
  15. Editorials
  16. Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics
  17. Lessons from controversy: biomarkers evaluation
  18. Commercial immunoassays in biomarkers studies: researchers beware!1)
  19. Trials and tribulations in lupus anticoagulant testing
  20. Reviews
  21. Mass spectrometry: a revolution in clinical microbiology?
  22. Chronic Chagas disease: from basics to laboratory medicine
  23. General Clinical Chemistry and Laboratory Medicine
  24. Shop for quality or quantity? Volumes and costs in clinical laboratories
  25. Minor improvement of venous blood specimen collection practices in primary health care after a large-scale educational intervention
  26. Evaluation of high resolution gel β2-transferrin for detection of cerebrospinal fluid leak
  27. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease
  28. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission
  29. Bone mass density selectively correlates with serum markers of oxidative damage in post-menopausal women
  30. Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in human plasma
  31. Performance of different screening methods for the determination of urinary glycosaminoclycans
  32. Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow’s milk allergy in toddlers
  33. An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation
  34. Serum levels of IgG antibodies against oxidized LDL and atherogenic indices in HIV-1-infected patients treated with protease inhibitors
  35. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays
  36. Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure
  37. Suitability of POC lactate methods for fetal and perinatal lactate testing: considerations for accuracy, specificity and decision making criteria
  38. Point-of-care testing on admission to the intensive care unit: lactate and glucose independently predict mortality
  39. Reference Values and Biological Variations
  40. CA125 reference values change in male and postmenopausal female subjects
  41. Distributions and ranges of values of blood and urinary biomarker of inflammation and oxidative stress in the workers engaged in office machine manufactures: evaluation of reference values
  42. Cancer Diagnostics
  43. Association of acute phase protein-haptoglobin, and epithelial-mesenchymal transition in buccal cancer: a preliminary report
  44. Comparison of diagnostic and prognostic performance of two assays measuring thymidine kinase 1 activity in serum of breast cancer patients
  45. Evaluation of the BRAHMS Kryptor® Thyroglobulin Minirecovery Test in patients with differentiated thyroid carcinoma
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2012-0408/html?lang=en
Scroll to top button